188 related articles for article (PubMed ID: 16102623)
61. Potential vascular mechanisms of ramipril induced increases in walking ability in patients with intermittent claudication.
Ahimastos AA; Latouche C; Natoli AK; Reddy-luthmoodoo M; Golledge J; Kingwell BA
Circ Res; 2014 Mar; 114(7):1144-55. PubMed ID: 24397981
[TBL] [Abstract][Full Text] [Related]
62. Association of thrombotic and fibrinolytic factors with severity of culprit lesion in patients with acute coronary syndromes without ST elevation.
Turker Y; Dogan A; Ozaydin M; Kaya S; Onal S; Akkaya M; Erdogan D
South Med J; 2010 Apr; 103(4):289-94. PubMed ID: 20224507
[TBL] [Abstract][Full Text] [Related]
63. Thrombin generation mediators and markers in sepsis-associated coagulopathy and their modulation by recombinant thrombomodulin.
Hoppensteadt D; Tsuruta K; Cunanan J; Hirman J; Kaul I; Osawa Y; Fareed J
Clin Appl Thromb Hemost; 2014 Mar; 20(2):129-35. PubMed ID: 23804232
[TBL] [Abstract][Full Text] [Related]
64. Plasma levels of the molecular markers of coagulation and fibrinolysis in patients with peripheral arterial disease.
Strano A; Hoppensteadt D; Walenga JM; Fareed J; Sabbá C; Berardi E; Allegra C; Carlizza A; Binaghi F; Fronteddu F; Del Guercio R; Del Guercio M; Pinto A; Alletto G; Nazzari M; Ferrari PA
Semin Thromb Hemost; 1996; 22 Suppl 1():35-40. PubMed ID: 8807727
[TBL] [Abstract][Full Text] [Related]
65. [Thrombocytopenia induced by lipopolysaccharide may be not related to coagulation and inflammatory response].
Xiang J; Fangchao Y; Bing W; Yongqiang W; Shuhua C; Yuliang W
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2015 Sep; 27(9):754-8. PubMed ID: 26955703
[TBL] [Abstract][Full Text] [Related]
66. Management of patients with intermittent claudication.
Olin JW
Int J Clin Pract; 2002 Nov; 56(9):687-93. PubMed ID: 12469984
[TBL] [Abstract][Full Text] [Related]
67. Role of hemostatic risk factors for restenosis in peripheral arterial occlusive disease after transluminal angioplasty.
Tschopl M; Tsakiris DA; Marbet GA; Labs KH; Jäger K
Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):3208-14. PubMed ID: 9409313
[TBL] [Abstract][Full Text] [Related]
68. Effects of aspirin DL-lysine on thrombin generation in unstable angina pectoris.
Yasu T; Oshima S; Imanishi M; Nonogi H; Haze K; Kuramochi M; Omae T; Hayashi Y; Yamamoto S
Am J Cardiol; 1993 May; 71(13):1164-8. PubMed ID: 8480641
[TBL] [Abstract][Full Text] [Related]
69. Aspirin in peripheral arterial disease: breakthrough or pitfall?
Singer E; Imfeld S; Hoffmann U; Buschmann I; Labs KH; Jaeger KA
Vasa; 2006 Aug; 35(3):174-7. PubMed ID: 16941406
[TBL] [Abstract][Full Text] [Related]
70. Endovascular brachytherapy: effect on acute inflammatory response after percutaneous femoropopliteal arterial interventions.
Schillinger M; Mlekusch W; Wolfram RM; Budinsky AC; Exner M; Rumpold H; Wagner O; Pokrajac B; Pötter R; Minar E
Radiology; 2004 Feb; 230(2):556-60. PubMed ID: 14752194
[TBL] [Abstract][Full Text] [Related]
71. Effects of clopidogrel and high dose aspirin on survival of skin flaps in rats.
Akan M; Cakir B; Misirlioğlu A; Yildirim S; Taylan G; Aköz T
Scand J Plast Reconstr Surg Hand Surg; 2005; 39(1):7-10. PubMed ID: 15848959
[TBL] [Abstract][Full Text] [Related]
72. Aspirin resistance in children and young adults with splenectomized thalassemia diseases.
Sirachainan N; Wijarn P; Chuansumrit A; Kadegasem P; Wongwerawattanakoon P; Soisamrong A
Thromb Res; 2015 May; 135(5):916-22. PubMed ID: 25776469
[TBL] [Abstract][Full Text] [Related]
73. Evaluation of analytic and clinical performance of thrombin-antithrombin complex and D-dimer assay in prognosis of acute ischemic stroke.
Ye N; Liu Z; Wang X; Xu X; Wu W
Blood Coagul Fibrinolysis; 2020 Jul; 31(5):303-309. PubMed ID: 32371663
[TBL] [Abstract][Full Text] [Related]
74. The role of coagulation and inflammation after angioplasty in patients with peripheral arterial disease.
Wahlgren CM; Sten-Linder M; Egberg N; Kalin B; Blohmé L; Swedenborg J
Cardiovasc Intervent Radiol; 2006; 29(4):530-5. PubMed ID: 16729229
[TBL] [Abstract][Full Text] [Related]
75. Treatment of intermittent claudication with antiplatelet agents.
Giansante C; Calabrese S; Fisicaro M; Fiotti N; Mitri E
J Int Med Res; 1990; 18(5):400-7. PubMed ID: 2147914
[TBL] [Abstract][Full Text] [Related]
76. Diagnostic significance of thrombin-antithrombin III complex (TAT) and D-dimer in patients with deep venous thrombosis.
Sassa H; Sone T; Tsuboi H; Kondo J; Yabashi T
Jpn Circ J; 1996 Apr; 60(4):201-6. PubMed ID: 8726168
[TBL] [Abstract][Full Text] [Related]
77. A randomized comparison of the effects of aspirin and clopidogrel on thrombotic risk factors and C-reactive protein following myocardial infarction: the CADET trial.
Woodward M; Lowe GD; Francis LM; Rumley A; Cobbe SM;
J Thromb Haemost; 2004 Nov; 2(11):1934-40. PubMed ID: 15550024
[TBL] [Abstract][Full Text] [Related]
78. Prognostic value of D-dimer and markers of coagulation for stratification of abdominal aortic aneurysm growth.
Sundermann AC; Saum K; Conrad KA; Russell HM; Edwards TL; Mani K; Björck M; Wanhainen A; Owens AP
Blood Adv; 2018 Nov; 2(22):3088-3096. PubMed ID: 30442686
[TBL] [Abstract][Full Text] [Related]
79. Peripheral angioplasty with same-day discharge in patients with intermittent claudication.
Akopian G; Katz SG
J Vasc Surg; 2006 Jul; 44(1):115-8. PubMed ID: 16730157
[TBL] [Abstract][Full Text] [Related]
80. The use of coagulation activation markers (soluble fibrin polymer, TpP, prothrombin fragment 1.2, thrombin-antithrombin, and D-dimer) in the assessment of hypercoagulability in patients with inherited and acquired prothrombotic disorders.
Arkel YS; Paidas MJ; Ku DH
Blood Coagul Fibrinolysis; 2002 Apr; 13(3):199-205. PubMed ID: 11943933
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]